DNCB shows hormetic effects in THP 1 cells: low-dose enhancement of metabolic activity

To understand how chemicals interact with the human body, scientists often look at the immune system's frontline defenders. These are specialized cells that patrol the bloodstream, ready to recognize and react to foreign invaders or irritants. When these cells encounter a substance, they can become activated, changing their behavior and surface features to signal danger or begin a repair process. A key part of this reaction involves the cell's internal energy management. Just as a living organism needs fuel to move and think, these immune cells require a steady supply of metabolic energy to function. Scientists have long known that many chemicals can harm these cells, but the relationship between the amount of a chemical and the cell's reaction is not always a straight line. Sometimes, very small amounts of a substance do not cause damage but instead seem to give the cell a slight boost, a phenomenon researchers call a hormetic effect. Understanding these subtle responses at low doses is crucial for accurately assessing the safety of chemicals we encounter in our daily lives.

In a recent study, researchers turned their attention to a chemical called 2,4-dinitrochlorobenzene, often referred to as DNCB. This substance is well-known in the scientific community as a potent skin sensitizer, meaning it can trigger allergic reactions on the skin, and it has a history of use in both laboratory research and clinical treatments. While scientists have studied DNCB extensively, this new work focused specifically on what happens when cells are exposed to very low levels of it. The goal was to see if these tiny doses might trigger a hormetic response, potentially by activating a natural defense pathway within the cell that helps it manage stress. To investigate this, the team used THP-1 cells, a type of human immune cell grown in the lab, and treated them with small amounts of DNCB. They then measured two specific things to see how the cells reacted: their metabolic activity, which indicates how much energy they were using, and their immune activation, which they checked by looking at specific markers on the cell's surface.

The results revealed a clear pattern of stimulation at the lowest doses. When the cells were grown at a lower density and treated with a concentration of 0.05 micromolar DNCB, their metabolic activity jumped significantly. Instead of slowing down or dying, these cells became more active, reaching a level of energy use that was about 125 percent of what was observed in untreated control cells. This boost in activity was seen at two different points in time, suggesting a consistent response. The effect was also visible, though slightly less pronounced, when the cells were grown at a higher density. This finding confirms that at very low concentrations, the chemical does not act as a poison but rather as a mild stimulant for the cell's energy systems.

However, the story was different when the researchers looked at the immune activation side of the equation. While the cells were burning more energy, they did not appear to be ramping up their alarm signals. In fact, the study observed a slight decrease in the expression of two specific surface markers, CD86 and CD54, which are typically used to gauge how activated an immune cell is. At a concentration of 0.5 micromolar, the levels of these markers dropped by up to 16 percent and 12 percent respectively, compared to the untreated cells. This suggests that while the low dose of DNCB gave the cells a metabolic lift, it did not trigger the full immune response one might expect from a sensitizer. The researchers conclude that these findings highlight a critical need to include very low concentrations when testing how chemicals affect the body. By ignoring these small doses, scientists might miss important nuances in how a substance behaves, potentially leading to an incomplete picture of the risks involved.